Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pugh

Showing results (501-510 of 602) with videos related to

Pageof 61
Sort By:
BJU International|June 11, 2015
Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillanceJohn W Davis, John F Ward, Curtis A Pettaway, et al.
Oncogene|June 10, 2014
Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequencesT J Pugh, W Yu, J Yang, et al.
Genes|February 25, 2023
Molecular Genetic Characteristics of <i>FANCI</i>, a Proposed New Ovarian Cancer Predisposing GeneCaitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya, et al.
Nature Communications|September 2, 2023
Immunophenotypic correlates of sustained MRD negativity in patients with multiple myelomaDavid G Coffey, Francesco Maura, Edgar Gonzalez-Kozlova, et al.
Nature Communications|May 10, 2023
Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilitiesSuganth Suppiah, Sheila Mansouri, Yasin Mamatjan, et al.
Nature Communications|August 30, 2020
Wnt activation as a therapeutic strategy in medulloblastomaBranavan Manoranjan, Chitra Venugopal, David Bakhshinyan, et al.
Nature Medicine|February 7, 2017
A distinct innate lymphoid cell population regulates tumor-associated T cellsSarah Q Crome, Linh T Nguyen, Sandra Lopez-Verges, et al.
Nature Communications|August 26, 2025
Peripheral blood DNA methylation predicts the early onset of primary tumor in TP53 mutation carriersVallijah Subasri, Benjamin Brew, Brianne Laverty, et al.
BMJ Open|October 1, 2021
Implementation of serological and molecular tools to inform COVID-19 patient management: protocol for the GENCOV prospective cohort studyJennifer Taher, Chloe Mighton, Sunakshi Chowdhary, et al.
Eclinicalmedicine|February 21, 2024
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative dataAlberto Hernando-Calvo, Paul Nguyen, Philippe L Bedard, et al.
Pageof 61

Showing results (501-510 of 602) with videos related to

Sort By:
Pageof 61
BJU International|June 11, 2015
Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillanceJohn W Davis, John F Ward, Curtis A Pettaway, et al.
Oncogene|June 10, 2014
Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequencesT J Pugh, W Yu, J Yang, et al.
Genes|February 25, 2023
Molecular Genetic Characteristics of <i>FANCI</i>, a Proposed New Ovarian Cancer Predisposing GeneCaitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya, et al.
Nature Communications|September 2, 2023
Immunophenotypic correlates of sustained MRD negativity in patients with multiple myelomaDavid G Coffey, Francesco Maura, Edgar Gonzalez-Kozlova, et al.
Nature Communications|May 10, 2023
Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilitiesSuganth Suppiah, Sheila Mansouri, Yasin Mamatjan, et al.
Nature Communications|August 30, 2020
Wnt activation as a therapeutic strategy in medulloblastomaBranavan Manoranjan, Chitra Venugopal, David Bakhshinyan, et al.
Nature Medicine|February 7, 2017
A distinct innate lymphoid cell population regulates tumor-associated T cellsSarah Q Crome, Linh T Nguyen, Sandra Lopez-Verges, et al.
Nature Communications|August 26, 2025
Peripheral blood DNA methylation predicts the early onset of primary tumor in TP53 mutation carriersVallijah Subasri, Benjamin Brew, Brianne Laverty, et al.
BMJ Open|October 1, 2021
Implementation of serological and molecular tools to inform COVID-19 patient management: protocol for the GENCOV prospective cohort studyJennifer Taher, Chloe Mighton, Sunakshi Chowdhary, et al.
Eclinicalmedicine|February 21, 2024
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative dataAlberto Hernando-Calvo, Paul Nguyen, Philippe L Bedard, et al.
Pageof 61